MEDICINAL PLANTS USED FOR DIABETIC PATIENTS IN PARAGUAY
DOI:
https://doi.org/10.14450/2318-9312.v27.e4.a2015.pp214-220Keywords:
medicinal plants, type 2 diabetes mellitus, primary health careAbstract
A large percentage of the world population use medicinal plants.. In Paraguay, there are several plant species used for medicinal purposes to various conditions, including diabetes. This study aimed to determine the medicinal plants used by patients visiting the National Programm for Diabetes Health Center No. 9, in the city of Asunción. The Programm is part of a program of pharmaceutical care developed proposed as part of the Doctoral Thesis: “Evaluation of a pharmaceutical care program in patients with type 2 diabetes mellitus.” An interview was done with 61 patients with type 2 diabetes mellitus that participated in this program between October and December 2011. From 61 patients interviewed, 17 were men and 44 women; the average age was 55 ± 10.6 years; 45.9% lived in Asuncion and 54.1% in different cities of the Central Department. 78.1% said they use herbs without a prescription, 18.8% do not use medicinal plants, and 3.1% did not answer the question. The patients reported 33 plant species used for medicinal purposes, distributed in 25 families. Asteraceae was the mostly represented with 21.6%; the most used part was the leaf (48.5%); the form of employment was tereré, a traditional drink of Paraguay very similar to mate (infusion of yerba mate), with 51.5%. The five most cited species were: Moringa oleifera (Fabaceae); Artemisia absinthium (Asteraceae), Tithonia diversifolia (Asteraceae), Baccharis trimera (Asteraceae) and Stevia rebaudiana (Asteraceae). Patients with type 2 diabetes mellitus using medicinal plants, do concomitantly with conventional drugs, of which 47% are for the cardiovascular system, 26% are antidiabetics and 17% for the nervous system.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
- Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).